Thomson Reuters Thomson Pharma




Benefits to SMEs

Vision and luck aren't enough to guarantee a healthy business. Successful companies grow because they've given themselves an advantage — the market knowledge and strategic intelligence on which to make fast, clever decisions.

There's no better advantage you can give your company than Thomson Pharma.

Companies and research organizations of all sizes trust our information because we provide a one-stop-shop for quality information on powerful platforms, accompanied by intuitive analytical tools, and backed up by dedicated support teams.


The information you need on tap

Thomson Pharma gives you complete access to the best pharmaceutical information from the extensive collection of scientific, healthcare and financial databases offered by Thomson Reuters, the global leader in providing integrated information solutions.

Its hyperlinks encourage you to search seamlessly across the data, spinning your thoughts into new areas, new lines of inquiry, new fields of research.

Best of all, it's all in one place, fully indexed, cross-referenced and integrated into a single easy-to-use resource. So you need only one login, and one subscription per user for unlimited searches.


Access to match your budget

Our pricing structure is based on the size of your organization. We'll work with you to create the best option for your budget.

We're constantly improving and developing Thomson Pharma, adding new specialized modules and subjects. But you only pay for the level of access you choose.

Compared to the way your business typically might be working now — legacy indexing systems, multiple interfaces, complex data, even paper sources — you'll soon realize benefits in saved time and effort.


Ready to experience Thomson Pharma for yourself?

To continue to explore the content and benefits of Thomson Pharma, click on the link above or use the menu on the left of the page. If you're ready to contact us or want to register for a Thomson Pharma trial,
click here.


Free new publication

The Ones To Watch — our quarterly pipeline changes review

The Ones to Watch

Thomson Reuters takes the pulse of the industry with this lively review of the latest phase changes in the pharmaceutical pipeline.

Sign up and receive this free quarterly review in PDF format, delivered direct to your desktop. Registration is simple, free and without commitment.

Click here to register

Flash presentations

These presentations require Flash Player 8, minimum 512k line speed.




Disclaimer | Terms of Use
Privacy Policy | Copyright